These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24155378)

  • 21. Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.
    Jia L; Li H; Sun Y
    Neoplasia; 2011 Jun; 13(6):561-9. PubMed ID: 21677879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
    Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
    Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase.
    Romani B; Cohen EA
    Curr Opin Virol; 2012 Dec; 2(6):755-63. PubMed ID: 23062609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MLN4924, a First-in-Class NEDD8-Activating Enzyme Inhibitor, Attenuates IFN-β Production.
    Song H; Huai W; Yu Z; Wang W; Zhao J; Zhang L; Zhao W
    J Immunol; 2016 Apr; 196(7):3117-23. PubMed ID: 26895833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.
    Nawrocki ST; Griffin P; Kelly KR; Carew JS
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1563-73. PubMed ID: 22799561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen.
    Yan ZH; Burkhardt A; Loke HK; Chen J; Xu Q; Brauer P; Ma J; Lin Y; Garcia K; Dick LR; Bembenek ME
    Anal Biochem; 2013 Aug; 439(2):109-15. PubMed ID: 23624319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overactivated neddylation pathway as a therapeutic target in lung cancer.
    Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
    J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity.
    Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM
    Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neddylation-Independent Activities of MLN4924.
    Mao H; Sun Y
    Adv Exp Med Biol; 2020; 1217():363-372. PubMed ID: 31898238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins.
    Wei W; Guo H; Gao Q; Markham R; Yu XF
    J Virol; 2014 Jan; 88(1):583-91. PubMed ID: 24173216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration.
    Reinhard C; Bottinelli D; Kim B; Luban J
    Retrovirology; 2014 Feb; 11():12. PubMed ID: 24485168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MLN4924 is an efficient inhibitor of NEDD8 conjugation in plants.
    Hakenjos JP; Richter R; Dohmann EM; Katsiarimpa A; Isono E; Schwechheimer C
    Plant Physiol; 2011 Jun; 156(2):527-36. PubMed ID: 21527421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting Neddylation with MLN4924 Suppresses Growth and Delays Multicellular Development in
    Huber RJ; Kim WD; Mathavarajah S
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.
    Brownell JE; Sintchak MD; Gavin JM; Liao H; Bruzzese FJ; Bump NJ; Soucy TA; Milhollen MA; Yang X; Burkhardt AL; Ma J; Loke HK; Lingaraj T; Wu D; Hamman KB; Spelman JJ; Cullis CA; Langston SP; Vyskocil S; Sells TB; Mallender WD; Visiers I; Li P; Claiborne CF; Rolfe M; Bolen JB; Dick LR
    Mol Cell; 2010 Jan; 37(1):102-11. PubMed ID: 20129059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma.
    Wang J; Wang S; Zhang W; Wang X; Liu X; Liu L; Li L; Liang Y; Yu J; Jeong LS; Jia L; Zhao H; Zhang Y
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1183-1188. PubMed ID: 28669728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme.
    Yang D; Tan M; Wang G; Sun Y
    PLoS One; 2012; 7(3):e34079. PubMed ID: 22457814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of lentiviral Vpx-CRL4 E3 ligase-mediated SAMHD1 degradation in the substrate adaptor protein DCAF1.
    Guo H; Zhang N; Shen S; Yu XF; Wei W
    Biochem Biophys Res Commun; 2019 Jun; 513(4):933-939. PubMed ID: 31003777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NEDD8 activating enzyme inhibitor MLN4924 mitigates doxorubicin-induced cardiotoxicity in mice.
    Chen KH; Sun JM; Lin L; Liu JW; Liu XY; Chen GD; Chen H; Chen ZY
    Free Radic Biol Med; 2024 Jul; 219():127-140. PubMed ID: 38614228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice.
    Yu H; Luo H; Chang L; Wang S; Geng X; Kang L; Zhong Y; Cao Y; Wang R; Yang X; Zhu Y; Shi MJ; Hu Y; Liu Z; Yin X; Ran Y; Yang H; Fan W; Zhao BQ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35101976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
    Xu GW; Toth JI; da Silva SR; Paiva SL; Lukkarila JL; Hurren R; Maclean N; Sukhai MA; Bhattacharjee RN; Goard CA; Medeiros B; Gunning PT; Dhe-Paganon S; Petroski MD; Schimmer AD
    PLoS One; 2014; 9(4):e93530. PubMed ID: 24691136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.